Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-093942
Filing Date
2021-07-20
Accepted
2021-07-20 16:01:53
Documents
12
Period of Report
2021-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2122548d1_8ka.htm   iXBRL 8-K/A 33643
  Complete submission text file 0001104659-21-093942.txt   216405

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20210609.xsd EX-101.SCH 3200
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20210609_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20210609_pre.xml EX-101.PRE 22720
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2122548d1_8ka_htm.xml XML 4800
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38067 | Film No.: 211101071
SIC: 2834 Pharmaceutical Preparations